Skip to main
AFMD
AFMD logo

Affimed (AFMD) Earnings Dates & Reports

Affimed (AFMD) Most Recent Earnings

Report DateNov 14, 2024
Period EndingQ3 2024
Est. EPS-$0.95
Actual EPS-$1.03
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Affimed (AFMD) Earnings per Share (EPS) History

Signup for full access
Browse free

Affimed (AFMD) Latest Earnings

The value each AFMD share was expected to gain vs. the value each share gained.

Affimed (AFMD) reported its most recent earnings on Nov 14, 2024 for Q3 2024, posting earnings per share (EPS) of -$1.03. This exceeded analysts' expectations of -$0.95 by 8.42%, marking a Miss.

For comparison, Affimed reported EPS of -$1.70 in the same quarter last year.

The company is expected to announce its next earnings report on 07/15/2025, with analysts projecting an EPS of -$0.54.

Affimed (AFMD) Earnings History

Earnings
Est. EPSActual EPSSurprise
Q1 2025Jul 15, 2025
-$0.54Next earnings call Jul. 15, 2025
Q3 2024Nov 14, 2024
-$0.95-$1.03+8.42%
DeckReportListen
Q2 2024Sep 5, 2024
-$0.98-$1.09+10.92%
Q1 2024Jun 12, 2024
-$1.54-$1.38-10.45%
Q4 2023Mar 28, 2024
-$1.67-$1.50-10.18%
View all

Affimed (AFMD) Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Affimed’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange
Nov 14, 2024
Sep 5, 2024
Jun 12, 2024
Mar 28, 2024

Affimed (AFMD) Earnings FAQs

Affimed (AFMD) last reported earnings on Nov 14, 2024 for Q3 2024, posting an EPS of -$1.03, which Miss the estimate of -$0.95 by 8.42%.

For Q3 2024, Affimed (AFMD) reported an EPS of -$1.03, missing analysts' estimate of -$0.95 by 8.42%.

For Q3 2024, Affimed (AFMD) Miss expectations with an actual EPS of -$1.03 vs. an estimated EPS of -$0.95.

Following the last earnings report on Nov 14, 2024, Affimed (AFMD)'s stock price moved — from — to —.

The next Affimed (AFMD) earnings call is scheduled for Jul. 15, 2025, where executives will discuss financial results and outlook.

Affimed (AFMD)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.